Concepedia

L-dopa treatment failure: explanation and correction.

Leonor Rivera‐Calimlim, Carlos A. Dujovne, James P. Morgan, Louis Lasagna, J. R. Bianchine

BMJ · 1970 · 92 citations · 6 references

DOIFull text

Open access

Concepts

Abstract

range (mean ± 2 standard deviations) for age for each immunoglobulin is given in parentheses and is derived from the data of Allanamith, McClellan, Butter- worth, and Maloney (1968).

References

6

Modification of Parkinsonism — Chronic Treatment with L-Dopa

George C. Cotzias, Paul S. Papavasiliou, Rosemary A. Gellene · New England Journal of Medicine · 1969 · 1.3K citations

, , +17

CEREBRAL ACCUMULATION AND METABOLISM OF C14-DOPA AFTER SELECTIVE INHIBITION OF PERIPHERAL DECARBOXYLASE

G. Bartholini, A. Pletscher · Journal of Pharmacology and Experimental Therapeutics · 1968 · 205 citations

, , +12

L-DOPA IN POSTENCEPHALITIC PARKINSONISM

Donald B. Calne, G M Stern, J A Sharkey et al. · The Lancet · 1969 · 146 citations

, , +12

Clinical pharmacology and therapeutics

M. J. Kendall, Richard Horton · Postgraduate Medical Journal · 1990 · 86 citations · Full text

, , +8

Treatment of Parkinsonism with Laevo-Dopa

C. Mawdsley · BMJ · 1970 · 75 citations · Full text

, , +12